Literature DB >> 22269477

Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis.

Nina L Cluny1, Raylene A Reimer, Keith A Sharkey.   

Abstract

Energy balance is controlled by centres of the brain which receive important inputs from the gastrointestinal tract, liver, pancreas, adipose tissue and skeletal muscle, mediated by many different signalling molecules. Obesity occurs when control of energy intake is not matched by the degree of energy expenditure. Obesity is not only a state of disordered energy balance it is also characterized by systemic inflammation. Systemic inflammation is triggered by the leakage of bacterial lipopolysaccharide through changes in intestinal permeability. The endocannabinoid system, consisting of the cannabinoid receptors, endogenous cannabinoid ligands and their biosynthetic and degradative enzymes, plays vital roles in the control of energy balance, the control of intestinal permeability and immunity. In this review we will discuss how the endocannabinoid system, intestinal microbiota and the brain-gut axis are involved in the regulation of energy balance and the development of obesity-associated systemic inflammation. Through direct and indirect actions throughout the body, the endocannabinoid system controls the development of obesity and its inflammatory complications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269477     DOI: 10.1016/j.bbi.2012.01.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

1.  Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.

Authors:  Zinah Zamil Al-Ghezi; Philip Brandon Busbee; Hasan Alghetaa; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

2.  Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.

Authors:  Robert B Laprairie; Amina M Bagher; Jillian L Rourke; Adel Zrein; Elizabeth A Cairns; Melanie E M Kelly; Christopher J Sinal; Pushkar M Kulkarni; Ganesh A Thakur; Eileen M Denovan-Wright
Journal:  Neuropharmacology       Date:  2019-03-30       Impact factor: 5.250

3.  A sequence-based variation map of zebrafish.

Authors:  Ashok Patowary; Ramya Purkanti; Meghna Singh; Rajendra Chauhan; Angom Ramcharan Singh; Mohit Swarnkar; Naresh Singh; Vikas Pandey; Carlos Torroja; Matthew D Clark; Jean-Pierre Kocher; Karl J Clark; Derek L Stemple; Eric W Klee; Stephen C Ekker; Vinod Scaria; Sridhar Sivasubbu
Journal:  Zebrafish       Date:  2013-03       Impact factor: 1.985

Review 4.  Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.

Authors:  Pietro Vajro; Giulia Paolella; Alessio Fasano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

Review 5.  Impacts of gut bacteria on human health and diseases.

Authors:  Yu-Jie Zhang; Sha Li; Ren-You Gan; Tong Zhou; Dong-Ping Xu; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2015-04-02       Impact factor: 5.923

Review 6.  Dietary sugars: their detection by the gut-brain axis and their peripheral and central effects in health and diseases.

Authors:  Melissa Ochoa; Jean-Paul Lallès; Charles-Henri Malbert; David Val-Laillet
Journal:  Eur J Nutr       Date:  2014-10-09       Impact factor: 5.614

7.  Endocannabinoids in the Gut.

Authors:  Nicholas V DiPatrizio
Journal:  Cannabis Cannabinoid Res       Date:  2016-02-24

8.  Epigenetic Interactions between Alcohol and Cannabinergic Effects: Focus on Histone Modification and DNA Methylation.

Authors:  Tiyash Parira; Alejandra Laverde; Marisela Agudelo
Journal:  J Alcohol Drug Depend       Date:  2017-03-20

9.  Molecular anatomy of the gut-brain axis revealed with transgenic technologies: implications in metabolic research.

Authors:  Swalpa Udit; Laurent Gautron
Journal:  Front Neurosci       Date:  2013-07-31       Impact factor: 4.677

10.  The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Authors:  Silvana Y Romero-Zerbo; María García-Fernández; Vanesa Espinosa-Jiménez; Macarena Pozo-Morales; Alejandro Escamilla-Sánchez; Lourdes Sánchez-Salido; Estrella Lara; Nadia Cobo-Vuilleumier; Alex Rafacho; Gabriel Olveira; Gemma Rojo-Martínez; Benoit R Gauthier; Isabel González-Mariscal; Francisco J Bermúdez-Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.